SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Atherosclerosis. 2022;360:27-33.

Changes in metabolic syndrome burden and risk of coronary artery calcification progression in statin-naïve young adults.

, , , , , , , , ,

제1저자 안효정, 이희선 · 교신저자 최수연

소속 (9)
  1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  2. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Cardiology, Seoul National University Hospital Healthcare System Gangnam Centre, Seoul, Republic of Korea.
  3. Department of Imaging, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
  4. Division of Cardiology, Yonsei Cardiovascular Centre, Yonsei University Health System, Seoul, Republic of Korea.
  5. Division of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  6. Department of Internal Medicine, Gangnam Heartscan Clinic, Seoul, Republic of Korea.
  7. Division of Cardiology, Heart Stroke & Vascular Institute, Samsung Medical Centre, Seoul, Republic of Korea.
  8. Division of Cardiology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  9. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Cardiology, Seoul National University Hospital Healthcare System Gangnam Centre, Seoul, Republic of Korea. Electronic address: sychoi1119@snuh.org.

Abstract

BACKGROUND AND AIMS We aimed to investigate the association between metabolic syndrome (MetS) and coronary artery calcium (CAC) progression in statin-naïve young adults.

METHODS From the KOrea Initiatives on Coronary Artery calcification registry, we included asymptomatic young adults aged 20-45 years who underwent serial CAC scans for routine health check-ups. The primary endpoint was CAC progression. We estimated the risk of CAC progression based on the presence and burden of MetS. Among participants with MetS, the temporal relationship between changes in metabolic burden and CAC progression was evaluated.

RESULTS Of 2151 young adults (mean age 41.3 ± 3.8 years; male 85.4%), 488 (22.7%) had MetS. The mean CAC score was 10.8 and 81.3% of them had a CAC score of zero at baseline. During follow-up (median, 2.1 years), CAC progression was observed in 325 (15.1%) adults. MetS was associated with an approximately 1.8-fold increased risk of CAC progression (adjusted hazard ratio [aHR] 1.83, p < 0.001). The risk of CAC progression was directly proportional to the metabolic burden. Elevated blood pressure and elevated triglyceride levels were independent components related to CAC progression, with the strongest contribution being made by elevated blood pressure (aHR 2.00, p < 0.001). A reduction in at least two metabolic burdens was associated with a halved risk of CAC progression in young adults having MetS (odds ratio 0.41, p = 0.018).

CONCLUSIONS In statin-naïve young adults, the metabolic burden was associated with a risk of CAC progression in a dose-dependent manner. Improvement in metabolic imbalance may have a preventive effect on CAC progression.

Copyright © 2022 Elsevier B.V. All rights reserved.

Keywords

Coronary artery calciumMetabolic burdenMetabolic syndromeYoung adult

Conflict of interest statement

Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

그 밖의 정보
출판 형태
Journal Article
저널
Atherosclerosis · eISSN 1879-1484
전자 출판
2022-10-07
MeSH
Male · Young Adult · Humans · Adult · Middle Aged · Metabolic Syndrome* / complications / epidemiology · Vascular Calcification* / diagnostic imaging / epidemiology · Coronary Vessels / diagnostic imaging / metabolism · Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use · Calcium / metabolism · Risk Factors · Coronary Artery Disease* / diagnostic imaging / epidemiology · Triglycerides / metabolism · Disease Progression
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors · Calcium · Triglycerides